Dyne Therapeutics to Present at Upcoming Investor Conferences
Dyne Therapeutics (NASDAQ: DYN), a clinical-stage company specializing in treatments for genetically driven neuromuscular diseases, has announced its participation in two major healthcare investor conferences in September 2025.
Management will present at the Cantor Global Healthcare Conference on September 5, 2025, at 9:45 a.m. ET, and at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 9:15 a.m. ET. Both events will take place in New York.
Investors can access live webcasts of the presentations through Dyne's website, with replays available for 90 days.
Dyne Therapeutics (NASDAQ: DYN), società clinica specializzata in terapie per malattie neuromuscolari di origine genetica, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a settembre 2025.
La direzione terrà una presentazione al Cantor Global Healthcare Conference il 5 settembre 2025 alle 9:45 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference l'8 settembre 2025 alle 9:15 ET. Entrambi gli eventi si svolgeranno a New York.
Gli investitori potranno seguire le presentazioni in webcast in diretta tramite il sito web di Dyne; le repliche saranno disponibili per 90 giorni.
Dyne Therapeutics (NASDAQ: DYN), una compañía en fase clínica especializada en tratamientos para enfermedades neuromusculares de origen genético, ha anunciado su participación en dos importantes conferencias para inversores del sector salud en septiembre de 2025.
La dirección presentará en el Cantor Global Healthcare Conference el 5 de septiembre de 2025 a las 9:45 ET y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 8 de septiembre de 2025 a las 9:15 ET. Ambos eventos se celebrarán en Nueva York.
Los inversores podrán acceder a las retransmisiones en directo a través del sitio web de Dyne; las repeticiones estarán disponibles durante 90 días.
Dyne Therapeutics (NASDAQ: DYN))는 유전성으로 발생하는 근신경계 질환 치료에 주력하는 임상 단계 기업으로, 2025년 9월에 열리는 두 건의 주요 의료 투자자 콘퍼런스에 참가한다고 발표했습니다.
경영진은 Cantor Global Healthcare Conference에서 2025년 9월 5일 동부표준시(ET) 기준 오전 9시 45분에, Morgan Stanley 23rd Annual Global Healthcare Conference에서 2025년 9월 8일 ET 기준 오전 9시 15분에 발표를 진행합니다. 두 행사는 모두 뉴욕에서 개최됩니다.
투자자는 Dyne 웹사이트를 통해 발표 생중계에 접속할 수 있으며, 다시보기는 90일 동안 제공됩니다.
Dyne Therapeutics (NASDAQ: DYN), société en phase clinique spécialisée dans les traitements des maladies neuromusculaires d'origine génétique, a annoncé sa participation à deux grandes conférences pour investisseurs du secteur de la santé en septembre 2025.
La direction fera une présentation au Cantor Global Healthcare Conference le 5 septembre 2025 à 9h45 ET, et au Morgan Stanley 23rd Annual Global Healthcare Conference le 8 septembre 2025 à 9h15 ET. Les deux événements se tiendront à New York.
Les investisseurs pourront suivre les webcasts en direct via le site de Dyne ; les rediffusions seront disponibles pendant 90 jours.
Dyne Therapeutics (NASDAQ: DYN), ein klinisch tätiges Unternehmen, das sich auf Therapien für genetisch bedingte neuromuskuläre Erkrankungen spezialisiert hat, gab seine Teilnahme an zwei bedeutenden Gesundheitsinvestoren-Konferenzen im September 2025 bekannt.
Das Management wird am Cantor Global Healthcare Conference am 5. September 2025 um 9:45 Uhr ET und am Morgan Stanley 23rd Annual Global Healthcare Conference am 8. September 2025 um 9:15 Uhr ET präsentieren. Beide Veranstaltungen finden in New York statt.
Investoren können die Präsentationen live per Webcast über die Dyne-Website verfolgen; Wiederholungen sind für 90 Tage verfügbar.
- None.
- None.
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:
- Cantor Global Healthcare Conference 2025, fireside chat on Friday, September 5, 2025 at 9:45 a.m. ET in New York
- Morgan Stanley 23rd Annual Global Healthcare Conference, fireside chat on Monday, September 8, 2025 at 9:15 a.m. ET in New York
A live webcast of each presentation will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.
About Dyne Therapeutics
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Contacts:
Investors
Mia Tobias
ir@dyne-tx.com
781-317-0353
Media
Stacy Nartker
snartker@dyne-tx.com
781-317-1938
FAQ
When is Dyne Therapeutics (DYN) presenting at the Cantor Global Healthcare Conference 2025?
What time is Dyne Therapeutics' presentation at the Morgan Stanley Healthcare Conference 2025?
Where can I watch Dyne Therapeutics' (DYN) investor conference presentations?
What type of company is Dyne Therapeutics (DYN)?
